- STAT+: Europe will accelerate its review of RevMed’s drugKailera's GLP-1 pill data raises concerns, FDA clears Vera autoimmune therapy, and more biotech news from The ReadoutSTAT · 17d ago↗ source
- STAT+: Prime Medicine claims victory in dispute over gene-editing technology with Beam TherapeuticsPrime Medicine said it had won an arbitration dispute against Beam Therapeutics, a clash that had pitted two well-backed gene-editing companies against each other.STAT · 17d ago↗ source
- STAT+: Pharmalittle: We’re reading about a Vera kidney drug approval, a U.K. Enhertu pricing deal, and moreThe FDA approved a kidney disease drug from Vera Therapeutics called Trutakna, to treat IgA nephropathySTAT · 17d ago